Covestor LTD Bridge Bio Pharma, Inc. Transaction History

Covestor LTD

$181 Million
Q3 2025

A detailed history of Covestor LTD transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Covestor LTD holds 1,629 shares of BBIO stock, worth $108,149. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,629

Previous 4,835 66.31%

Holding current value

$108,149

Previous $209,000 59.33%

% of portfolio

0.05%

Previous 0.12%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	SELL	$42.78 - $54.29 $137,152 - $174,053	-3,206 Reduced 66.31%	1,629 $85,000
Q2 2025 Aug 11, 2025	SELL	$30.14 - $45.12 $210,286 - $314,802	-6,977 Reduced 59.07%	4,835 $209,000
Q1 2025 May 12, 2025	SELL	$28.12 - $37.59 $257,466 - $344,174	-9,156 Reduced 43.67%	11,812 $408,000
Q4 2024 Feb 13, 2025	SELL	$22.35 - $29.5 $41,101 - $54,250	-1,839 Reduced 8.06%	20,968 $576,000
Q3 2024 Nov 01, 2024	BUY	$23.91 - $31.3 $249,429 - $326,521	10,432 Added 84.3%	22,807 $580,000

Q2 2024 Aug 09, 2024	BUY	$23.0 - $31.04 $85,514 - $115,406	3,718 Added 42.95%	12,375 $313,000
Q1 2024 May 10, 2024	BUY	$27.35 - $40.45 $38,454 - $56,872	1,406 Added 19.39%	8,657 $268,000
Q4 2023 Feb 09, 2024	SELL	$24.02 - $43.89 $56,110 - $102,527	-2,336 Reduced 24.37%	7,251 $292,000
Q3 2023 Nov 13, 2023	BUY	$16.89 - $35.01 $91,982 - $190,664	5,446 Added 131.51%	9,587 $252,000
Q2 2023 Aug 11, 2023	BUY	$13.29 - $18.01 $54,794 - $74,255	4,123 Added 22905.56%	4,141 $71,000
Q4 2022 Feb 13, 2023	SELL	$6.74 - $11.52 $6 - $11	-1 Reduced 5.26%	18 $0
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $23 - $37	-3 Reduced 13.64%	19 $0
Q2 2022 Aug 10, 2022	SELL	$5.21 - $12.14 $36 - $84	-7 Reduced 24.14%	22 $0
Q1 2022 May 13, 2022	SELL	$7.34 - $17.16 $645 - $1,510	-88 Reduced 75.21%	29 $0
Q4 2021 Feb 10, 2022	BUY	$11.38 - $53.41 $1,331 - $6,248	117 New	117 $2,000

Others Institutions Holding BBIO

# of Institutions

445

Shares Held

184M

Call Options Held

11.3M

Put Options Held

1.84M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $9.84B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account